Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis | 18 | 2022 | 658 | 4.110 |
Why?
|
Neutrophils | 25 | 2023 | 3711 | 3.480 |
Why?
|
Rheumatology | 16 | 2022 | 576 | 3.050 |
Why?
|
Antirheumatic Agents | 22 | 2024 | 1335 | 2.640 |
Why?
|
Megakaryocytes | 5 | 2022 | 542 | 2.600 |
Why?
|
Adenosine Deaminase | 7 | 2023 | 241 | 2.450 |
Why?
|
Macrophage Activation Syndrome | 9 | 2024 | 111 | 2.320 |
Why?
|
Immunoglobulin G | 17 | 2021 | 4554 | 2.240 |
Why?
|
Mast Cells | 14 | 2020 | 1544 | 2.230 |
Why?
|
Arthritis, Experimental | 11 | 2021 | 291 | 2.190 |
Why?
|
Arthritis, Rheumatoid | 23 | 2024 | 3695 | 2.090 |
Why?
|
Synovial Membrane | 10 | 2021 | 506 | 2.000 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 9 | 2021 | 297 | 1.910 |
Why?
|
Immunoglobulin Fc Fragments | 4 | 2021 | 279 | 1.900 |
Why?
|
Antigens, Ly | 4 | 2019 | 291 | 1.820 |
Why?
|
Emperipolesis | 3 | 2022 | 9 | 1.640 |
Why?
|
Lung Diseases | 6 | 2023 | 1884 | 1.630 |
Why?
|
Neutrophil Infiltration | 4 | 2019 | 390 | 1.360 |
Why?
|
Glycosylation | 10 | 2021 | 1123 | 1.310 |
Why?
|
Still's Disease, Adult-Onset | 2 | 2024 | 19 | 1.200 |
Why?
|
Antigen-Antibody Complex | 6 | 2019 | 517 | 1.120 |
Why?
|
Blood Platelets | 9 | 2022 | 2506 | 1.110 |
Why?
|
Arthritis, Psoriatic | 5 | 2011 | 215 | 1.070 |
Why?
|
Methotrexate | 8 | 2021 | 1720 | 1.070 |
Why?
|
Uveitis | 7 | 2022 | 375 | 1.070 |
Why?
|
Receptors, IgG | 8 | 2020 | 582 | 1.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2023 | 1675 | 1.050 |
Why?
|
Interleukin-1 | 9 | 2023 | 1262 | 0.960 |
Why?
|
Autoantibodies | 10 | 2023 | 2036 | 0.950 |
Why?
|
Synovial Fluid | 12 | 2022 | 394 | 0.930 |
Why?
|
Galactose | 2 | 2017 | 306 | 0.910 |
Why?
|
Pleurisy | 2 | 2013 | 53 | 0.900 |
Why?
|
Interleukins | 6 | 2019 | 791 | 0.900 |
Why?
|
Interleukin-1beta | 6 | 2022 | 972 | 0.890 |
Why?
|
Glucocorticoids | 11 | 2022 | 2107 | 0.830 |
Why?
|
Polymorphism, Single Nucleotide | 8 | 2021 | 15494 | 0.750 |
Why?
|
Data Display | 1 | 2021 | 182 | 0.740 |
Why?
|
Autoimmune Diseases | 7 | 2020 | 2130 | 0.740 |
Why?
|
Polysaccharides | 5 | 2021 | 1051 | 0.730 |
Why?
|
Interferon-alpha | 4 | 2021 | 895 | 0.710 |
Why?
|
Receptors, Fc | 3 | 2021 | 540 | 0.670 |
Why?
|
Inflammation | 14 | 2023 | 10578 | 0.660 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2021 | 2986 | 0.660 |
Why?
|
Receptors, Interleukin | 4 | 2014 | 245 | 0.650 |
Why?
|
Cell Communication | 4 | 2022 | 1619 | 0.650 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 4 | 2024 | 256 | 0.650 |
Why?
|
Rheumatic Diseases | 4 | 2021 | 590 | 0.620 |
Why?
|
Inflammasomes | 3 | 2023 | 493 | 0.620 |
Why?
|
Cytokines | 13 | 2023 | 7317 | 0.610 |
Why?
|
Humans | 156 | 2024 | 742088 | 0.610 |
Why?
|
Binding Sites, Antibody | 1 | 2017 | 349 | 0.600 |
Why?
|
Immune System Diseases | 2 | 2021 | 262 | 0.600 |
Why?
|
Agammaglobulinemia | 1 | 2018 | 167 | 0.580 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2017 | 102 | 0.580 |
Why?
|
Receptors, Cell Surface | 3 | 2017 | 2867 | 0.580 |
Why?
|
Biological Therapy | 1 | 2018 | 138 | 0.570 |
Why?
|
Temporomandibular Joint Disorders | 4 | 2022 | 215 | 0.570 |
Why?
|
Child | 55 | 2024 | 77478 | 0.570 |
Why?
|
HLA Antigens | 2 | 2019 | 1382 | 0.560 |
Why?
|
Pulmonary Alveoli | 1 | 2019 | 675 | 0.560 |
Why?
|
Receptors, CCR6 | 1 | 2016 | 80 | 0.560 |
Why?
|
Editorial Policies | 1 | 2021 | 451 | 0.550 |
Why?
|
Biological Products | 7 | 2023 | 856 | 0.550 |
Why?
|
Lupus Erythematosus, Systemic | 6 | 2020 | 2099 | 0.550 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2018 | 221 | 0.540 |
Why?
|
Mice | 46 | 2023 | 81045 | 0.540 |
Why?
|
T-Lymphocytes, Helper-Inducer | 5 | 2024 | 986 | 0.530 |
Why?
|
Dyspnea | 2 | 2013 | 1298 | 0.520 |
Why?
|
Immunity, Humoral | 1 | 2019 | 596 | 0.510 |
Why?
|
Isoantigens | 1 | 2017 | 567 | 0.500 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2017 | 774 | 0.500 |
Why?
|
Animals | 57 | 2023 | 168561 | 0.500 |
Why?
|
Toll-Like Receptors | 2 | 2019 | 592 | 0.490 |
Why?
|
Monocytes | 4 | 2019 | 2593 | 0.480 |
Why?
|
Peer Review, Research | 1 | 2017 | 329 | 0.470 |
Why?
|
Estrogens | 2 | 2021 | 1562 | 0.470 |
Why?
|
Terminology as Topic | 1 | 2021 | 1548 | 0.460 |
Why?
|
Mentors | 3 | 2018 | 630 | 0.460 |
Why?
|
Receptor, Anaphylatoxin C5a | 2 | 2010 | 90 | 0.460 |
Why?
|
Th17 Cells | 1 | 2020 | 765 | 0.460 |
Why?
|
Drug Hypersensitivity | 1 | 2022 | 883 | 0.460 |
Why?
|
Chemokines | 1 | 2017 | 954 | 0.440 |
Why?
|
Publishing | 1 | 2020 | 833 | 0.440 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2015 | 1470 | 0.430 |
Why?
|
bcl-X Protein | 1 | 2014 | 411 | 0.430 |
Why?
|
Advisory Committees | 1 | 2017 | 773 | 0.430 |
Why?
|
Anti-Inflammatory Agents | 2 | 2020 | 1788 | 0.430 |
Why?
|
Joints | 6 | 2014 | 326 | 0.430 |
Why?
|
Genetic Predisposition to Disease | 10 | 2021 | 17400 | 0.420 |
Why?
|
T-Lymphocytes | 4 | 2024 | 10163 | 0.420 |
Why?
|
Biomedical Research | 4 | 2018 | 3306 | 0.420 |
Why?
|
Child, Preschool | 28 | 2023 | 40955 | 0.420 |
Why?
|
Research | 1 | 2020 | 1999 | 0.410 |
Why?
|
Immunity, Innate | 4 | 2020 | 2956 | 0.400 |
Why?
|
Mice, Knockout | 13 | 2021 | 14554 | 0.400 |
Why?
|
Pseudomonas aeruginosa | 1 | 2018 | 1210 | 0.390 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 5 | 2023 | 546 | 0.380 |
Why?
|
Leukotriene B4 | 3 | 2023 | 293 | 0.370 |
Why?
|
Receptors, Interferon | 2 | 2020 | 115 | 0.370 |
Why?
|
MAP Kinase Signaling System | 1 | 2017 | 1525 | 0.360 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2023 | 4438 | 0.350 |
Why?
|
5-Lipoxygenase-Activating Proteins | 2 | 2020 | 32 | 0.350 |
Why?
|
Multigene Family | 1 | 2013 | 1102 | 0.350 |
Why?
|
Sacroiliitis | 2 | 2019 | 11 | 0.350 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2020 | 4414 | 0.350 |
Why?
|
Leukotriene C4 | 2 | 2020 | 97 | 0.340 |
Why?
|
STAT1 Transcription Factor | 2 | 2021 | 320 | 0.340 |
Why?
|
Periodicals as Topic | 1 | 2020 | 1431 | 0.340 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2020 | 144 | 0.330 |
Why?
|
Vasculitis | 3 | 2023 | 521 | 0.330 |
Why?
|
Computational Biology | 1 | 2021 | 3518 | 0.330 |
Why?
|
Hematopoietic System | 1 | 2008 | 108 | 0.330 |
Why?
|
Education, Medical, Continuing | 1 | 2014 | 839 | 0.320 |
Why?
|
Chromosome Inversion | 1 | 2008 | 127 | 0.320 |
Why?
|
Male | 62 | 2022 | 349538 | 0.320 |
Why?
|
Phenotype | 10 | 2023 | 16331 | 0.320 |
Why?
|
Lyme Disease | 3 | 2021 | 618 | 0.310 |
Why?
|
Adolescent | 29 | 2023 | 85649 | 0.310 |
Why?
|
Cell Polarity | 2 | 2021 | 644 | 0.300 |
Why?
|
Lung | 4 | 2019 | 9826 | 0.300 |
Why?
|
Hemorrhage | 1 | 2019 | 3461 | 0.300 |
Why?
|
Female | 61 | 2022 | 379592 | 0.300 |
Why?
|
Citrulline | 3 | 2016 | 105 | 0.290 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2023 | 609 | 0.290 |
Why?
|
Interferons | 2 | 2020 | 704 | 0.290 |
Why?
|
Polymorphism, Genetic | 2 | 2016 | 4328 | 0.280 |
Why?
|
Tryptases | 3 | 2015 | 190 | 0.280 |
Why?
|
Consensus | 7 | 2019 | 2935 | 0.280 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2015 | 595 | 0.270 |
Why?
|
Interinstitutional Relations | 2 | 2018 | 240 | 0.270 |
Why?
|
Genome-Wide Association Study | 6 | 2019 | 12220 | 0.270 |
Why?
|
Interferon-gamma | 3 | 2023 | 3199 | 0.260 |
Why?
|
Blood Sedimentation | 2 | 2019 | 231 | 0.260 |
Why?
|
Autoantigens | 5 | 2016 | 891 | 0.260 |
Why?
|
Clinical Protocols | 3 | 2018 | 1459 | 0.250 |
Why?
|
Mice, Inbred C57BL | 18 | 2021 | 21821 | 0.250 |
Why?
|
Flow Cytometry | 7 | 2019 | 5975 | 0.230 |
Why?
|
Serine Endopeptidases | 1 | 2008 | 1073 | 0.220 |
Why?
|
Jurkat Cells | 3 | 2021 | 742 | 0.220 |
Why?
|
Temporomandibular Joint | 3 | 2022 | 196 | 0.220 |
Why?
|
Raynaud Disease | 1 | 2003 | 67 | 0.220 |
Why?
|
Reactive Oxygen Species | 4 | 2019 | 2077 | 0.220 |
Why?
|
Adult | 27 | 2024 | 213712 | 0.220 |
Why?
|
Hereditary Autoinflammatory Diseases | 1 | 2023 | 39 | 0.210 |
Why?
|
Dendritic Cells | 1 | 2013 | 2723 | 0.210 |
Why?
|
NF-kappa B | 3 | 2020 | 2500 | 0.210 |
Why?
|
Osteoclasts | 3 | 2021 | 729 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.210 |
Why?
|
Estradiol | 2 | 2021 | 2021 | 0.200 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2183 | 0.200 |
Why?
|
Cell Movement | 4 | 2019 | 5212 | 0.200 |
Why?
|
Fibroblasts | 6 | 2018 | 4143 | 0.200 |
Why?
|
Immunologic Factors | 2 | 2019 | 1575 | 0.190 |
Why?
|
Synovitis | 2 | 2016 | 209 | 0.190 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3766 | 0.190 |
Why?
|
Glucose-6-Phosphate Isomerase | 2 | 2015 | 52 | 0.190 |
Why?
|
Coronary Aneurysm | 1 | 2023 | 237 | 0.190 |
Why?
|
Occupational Therapy | 2 | 2019 | 134 | 0.190 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2020 | 364 | 0.190 |
Why?
|
Cell-Derived Microparticles | 2 | 2015 | 168 | 0.190 |
Why?
|
Dioxygenases | 1 | 2022 | 316 | 0.190 |
Why?
|
Peritonitis | 2 | 2021 | 365 | 0.190 |
Why?
|
Sequence Analysis, RNA | 4 | 2021 | 2011 | 0.190 |
Why?
|
Cells, Cultured | 11 | 2021 | 19223 | 0.180 |
Why?
|
Chemotaxis | 1 | 2023 | 607 | 0.180 |
Why?
|
Prevotella | 1 | 2020 | 79 | 0.180 |
Why?
|
Tarsus, Animal | 1 | 2019 | 5 | 0.180 |
Why?
|
Immunosuppressive Agents | 3 | 2019 | 4147 | 0.180 |
Why?
|
Interferon Type I | 1 | 2023 | 542 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-maf | 1 | 2019 | 71 | 0.180 |
Why?
|
Polyarteritis Nodosa | 1 | 2020 | 66 | 0.180 |
Why?
|
RANK Ligand | 1 | 2021 | 326 | 0.180 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 132 | 0.180 |
Why?
|
Borrelia burgdorferi | 1 | 2021 | 180 | 0.180 |
Why?
|
STAT5 Transcription Factor | 1 | 2020 | 259 | 0.170 |
Why?
|
Infant | 11 | 2021 | 35070 | 0.170 |
Why?
|
Macrophages | 4 | 2021 | 5655 | 0.170 |
Why?
|
Tuberculosis | 3 | 2019 | 1904 | 0.170 |
Why?
|
Adoptive Transfer | 1 | 2021 | 844 | 0.170 |
Why?
|
Alleles | 4 | 2024 | 6931 | 0.170 |
Why?
|
Proteoglycans | 2 | 2015 | 834 | 0.170 |
Why?
|
Eosinophilia | 1 | 2023 | 531 | 0.160 |
Why?
|
Macrophages, Peritoneal | 1 | 2019 | 251 | 0.160 |
Why?
|
Genetic Loci | 5 | 2021 | 2572 | 0.160 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 730 | 0.160 |
Why?
|
Heart Defects, Congenital | 2 | 2020 | 4566 | 0.160 |
Why?
|
Disease Models, Animal | 7 | 2019 | 18006 | 0.160 |
Why?
|
src-Family Kinases | 2 | 2020 | 551 | 0.160 |
Why?
|
Interleukin-10 | 2 | 2021 | 1200 | 0.160 |
Why?
|
Mice, Transgenic | 9 | 2020 | 9735 | 0.160 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2023 | 570 | 0.160 |
Why?
|
Physical Therapy Modalities | 2 | 2019 | 547 | 0.160 |
Why?
|
Platelet Membrane Glycoproteins | 2 | 2017 | 293 | 0.160 |
Why?
|
Interleukin-18 | 1 | 2019 | 248 | 0.160 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6382 | 0.150 |
Why?
|
Serpins | 1 | 2019 | 247 | 0.150 |
Why?
|
Antigens, Bacterial | 2 | 2021 | 1170 | 0.150 |
Why?
|
Nuclear Envelope | 1 | 2019 | 172 | 0.150 |
Why?
|
NF-E2 Transcription Factor, p45 Subunit | 1 | 2017 | 58 | 0.150 |
Why?
|
Pasteurellaceae Infections | 1 | 2016 | 3 | 0.150 |
Why?
|
Receptors, Interleukin-1 | 1 | 2018 | 261 | 0.150 |
Why?
|
Leukocytes, Mononuclear | 2 | 2021 | 1835 | 0.150 |
Why?
|
Endemic Diseases | 2 | 2018 | 182 | 0.150 |
Why?
|
B-Lymphocytes | 3 | 2023 | 4664 | 0.150 |
Why?
|
Mycobacterium Infections | 1 | 2017 | 119 | 0.150 |
Why?
|
Dermatomyositis | 1 | 2019 | 223 | 0.150 |
Why?
|
Osteogenesis | 2 | 2021 | 1299 | 0.150 |
Why?
|
Spondylarthritis | 1 | 2018 | 62 | 0.150 |
Why?
|
Diagnosis, Differential | 8 | 2019 | 12958 | 0.150 |
Why?
|
Basophils | 1 | 2019 | 389 | 0.140 |
Why?
|
Ferritins | 1 | 2019 | 590 | 0.140 |
Why?
|
Fertility Agents, Female | 1 | 2017 | 99 | 0.140 |
Why?
|
Cell Separation | 2 | 2019 | 1749 | 0.140 |
Why?
|
Leukocytosis | 2 | 2018 | 247 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 540 | 0.140 |
Why?
|
Goserelin | 1 | 2017 | 127 | 0.140 |
Why?
|
Leukocyte Count | 2 | 2018 | 1583 | 0.140 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 874 | 0.140 |
Why?
|
Cell Differentiation | 4 | 2021 | 11470 | 0.140 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2017 | 129 | 0.140 |
Why?
|
Genetic Diseases, Inborn | 1 | 2001 | 587 | 0.140 |
Why?
|
Physical Examination | 1 | 2022 | 1239 | 0.140 |
Why?
|
Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2016 | 33 | 0.140 |
Why?
|
Endosomes | 1 | 2019 | 520 | 0.140 |
Why?
|
Rheumatoid Factor | 1 | 2016 | 188 | 0.140 |
Why?
|
Cytoplasm | 2 | 2019 | 1539 | 0.140 |
Why?
|
GPI-Linked Proteins | 1 | 2017 | 434 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 657 | 0.140 |
Why?
|
Registries | 5 | 2018 | 8077 | 0.140 |
Why?
|
Endothelium | 1 | 2018 | 778 | 0.130 |
Why?
|
Gout | 1 | 2022 | 556 | 0.130 |
Why?
|
Receptors, Mitogen | 1 | 2015 | 62 | 0.130 |
Why?
|
Fullerenes | 1 | 2015 | 14 | 0.130 |
Why?
|
Capillary Permeability | 2 | 2012 | 798 | 0.130 |
Why?
|
Toe Joint | 1 | 2015 | 18 | 0.130 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2017 | 275 | 0.130 |
Why?
|
HCT116 Cells | 1 | 2016 | 408 | 0.130 |
Why?
|
Drug Approval | 1 | 2022 | 740 | 0.130 |
Why?
|
Bone Remodeling | 1 | 2019 | 575 | 0.130 |
Why?
|
Phosphorylation | 4 | 2021 | 8436 | 0.130 |
Why?
|
Interleukin-6 | 2 | 2022 | 3199 | 0.130 |
Why?
|
Heart | 1 | 2008 | 4462 | 0.130 |
Why?
|
Phospholipases A2, Secretory | 1 | 2015 | 31 | 0.130 |
Why?
|
Leuprolide | 1 | 2017 | 303 | 0.130 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2019 | 1155 | 0.130 |
Why?
|
Signal Transduction | 8 | 2023 | 23387 | 0.130 |
Why?
|
Group II Phospholipases A2 | 1 | 2014 | 13 | 0.130 |
Why?
|
Bone Marrow Cells | 2 | 2021 | 2513 | 0.130 |
Why?
|
Adrenal Cortex Hormones | 2 | 2020 | 1847 | 0.130 |
Why?
|
Disease Progression | 4 | 2019 | 13256 | 0.120 |
Why?
|
Immunoglobulin Constant Regions | 1 | 2014 | 59 | 0.120 |
Why?
|
High-Throughput Screening Assays | 2 | 2018 | 944 | 0.120 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2017 | 625 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2019 | 1221 | 0.120 |
Why?
|
Fontan Procedure | 1 | 2020 | 768 | 0.120 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2018 | 469 | 0.120 |
Why?
|
Finger Joint | 1 | 2015 | 108 | 0.120 |
Why?
|
Platelet Activation | 3 | 2014 | 671 | 0.120 |
Why?
|
Frozen Sections | 1 | 2015 | 155 | 0.120 |
Why?
|
Case-Control Studies | 11 | 2021 | 21719 | 0.120 |
Why?
|
Arthritis, Infectious | 2 | 2018 | 367 | 0.120 |
Why?
|
Helminthiasis | 1 | 2014 | 66 | 0.120 |
Why?
|
Congenital Disorders of Glycosylation | 1 | 2014 | 45 | 0.120 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2019 | 834 | 0.120 |
Why?
|
Interferon-beta | 1 | 2015 | 323 | 0.120 |
Why?
|
Paraffin Embedding | 1 | 2015 | 299 | 0.120 |
Why?
|
Point Mutation | 2 | 2014 | 1624 | 0.120 |
Why?
|
Major Histocompatibility Complex | 1 | 2016 | 935 | 0.120 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 401 | 0.110 |
Why?
|
Membrane Transport Proteins | 1 | 2019 | 1028 | 0.110 |
Why?
|
Cartilage Diseases | 1 | 2015 | 160 | 0.110 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1363 | 0.110 |
Why?
|
Pilot Projects | 4 | 2022 | 8297 | 0.110 |
Why?
|
Aromatase Inhibitors | 1 | 2017 | 491 | 0.110 |
Why?
|
Gene Order | 1 | 2013 | 176 | 0.110 |
Why?
|
Ophthalmology | 1 | 2019 | 506 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 573 | 0.110 |
Why?
|
Antibodies, Bacterial | 2 | 2021 | 1469 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2023 | 62966 | 0.110 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 1004 | 0.110 |
Why?
|
Comparative Effectiveness Research | 1 | 2018 | 681 | 0.110 |
Why?
|
Premenopause | 1 | 2017 | 1033 | 0.110 |
Why?
|
Disease Management | 2 | 2014 | 2450 | 0.110 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 2012 | 34 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2276 | 0.100 |
Why?
|
Reference Values | 1 | 2019 | 4982 | 0.100 |
Why?
|
HIV Antigens | 1 | 2013 | 347 | 0.100 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2014 | 440 | 0.100 |
Why?
|
Lectins, C-Type | 1 | 2015 | 588 | 0.100 |
Why?
|
Receptors, Leukotriene B4 | 1 | 2012 | 94 | 0.100 |
Why?
|
Leukocytes | 2 | 2017 | 2039 | 0.100 |
Why?
|
Syndrome | 2 | 2013 | 3248 | 0.100 |
Why?
|
Feces | 1 | 2018 | 1394 | 0.100 |
Why?
|
Sensitivity and Specificity | 4 | 2021 | 14720 | 0.100 |
Why?
|
Societies, Medical | 2 | 2014 | 3740 | 0.100 |
Why?
|
Needs Assessment | 1 | 2018 | 1146 | 0.100 |
Why?
|
Periodontitis | 1 | 2016 | 553 | 0.100 |
Why?
|
Microspheres | 1 | 2014 | 777 | 0.100 |
Why?
|
Neutrophil Activation | 1 | 2012 | 186 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2018 | 3336 | 0.100 |
Why?
|
Lymphocytes | 1 | 2019 | 2614 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2018 | 1780 | 0.100 |
Why?
|
Peritoneum | 1 | 2012 | 226 | 0.100 |
Why?
|
Hip Joint | 1 | 2018 | 1002 | 0.100 |
Why?
|
Cell Line | 4 | 2021 | 15994 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3862 | 0.100 |
Why?
|
Histones | 1 | 2021 | 2597 | 0.090 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2017 | 1185 | 0.090 |
Why?
|
Stem Cell Transplantation | 1 | 2019 | 1618 | 0.090 |
Why?
|
Staining and Labeling | 1 | 2015 | 1099 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 13921 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2505 | 0.090 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2021 | 4379 | 0.090 |
Why?
|
Cluster Analysis | 3 | 2019 | 2713 | 0.090 |
Why?
|
Antibodies | 2 | 2023 | 2459 | 0.090 |
Why?
|
Mass Screening | 3 | 2019 | 5238 | 0.090 |
Why?
|
Pediatrics | 2 | 2016 | 3462 | 0.090 |
Why?
|
Nanostructures | 1 | 2015 | 550 | 0.090 |
Why?
|
Knee Joint | 2 | 2021 | 1679 | 0.090 |
Why?
|
Feedback, Physiological | 1 | 2012 | 479 | 0.090 |
Why?
|
Pneumonia | 2 | 2021 | 2117 | 0.090 |
Why?
|
Bayes Theorem | 1 | 2018 | 2303 | 0.090 |
Why?
|
Sex Factors | 2 | 2017 | 10392 | 0.090 |
Why?
|
Age of Onset | 2 | 2006 | 3266 | 0.090 |
Why?
|
Extracellular Matrix | 2 | 2015 | 1740 | 0.090 |
Why?
|
Androgens | 1 | 2017 | 1271 | 0.090 |
Why?
|
Fibrinogen | 1 | 2012 | 894 | 0.090 |
Why?
|
Spleen | 2 | 2021 | 2359 | 0.080 |
Why?
|
Mycobacterium tuberculosis | 1 | 2019 | 1825 | 0.080 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 2010 | 378 | 0.080 |
Why?
|
Respiratory Function Tests | 1 | 2013 | 1613 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2019 | 15056 | 0.080 |
Why?
|
Receptors, CXCR5 | 2 | 2019 | 92 | 0.080 |
Why?
|
Chronic Disease | 3 | 2016 | 9144 | 0.080 |
Why?
|
Immunocompromised Host | 1 | 2013 | 847 | 0.080 |
Why?
|
Cyclooxygenase 1 | 1 | 2008 | 104 | 0.080 |
Why?
|
Choice Behavior | 1 | 2014 | 802 | 0.080 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3639 | 0.080 |
Why?
|
Postmenopause | 1 | 2017 | 2461 | 0.080 |
Why?
|
Inflammation Mediators | 2 | 2009 | 1889 | 0.080 |
Why?
|
Receptors, IgE | 2 | 2020 | 389 | 0.080 |
Why?
|
Zebrafish | 1 | 2019 | 2990 | 0.080 |
Why?
|
Blood Proteins | 1 | 2012 | 1122 | 0.080 |
Why?
|
Program Evaluation | 1 | 2016 | 2485 | 0.070 |
Why?
|
Immunization | 2 | 2022 | 1255 | 0.070 |
Why?
|
Gene Knockout Techniques | 2 | 2021 | 808 | 0.070 |
Why?
|
Prostaglandins | 1 | 2008 | 405 | 0.070 |
Why?
|
Patients | 1 | 2014 | 892 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2016 | 2257 | 0.070 |
Why?
|
Age Factors | 5 | 2018 | 18355 | 0.070 |
Why?
|
Complement Membrane Attack Complex | 2 | 2019 | 112 | 0.070 |
Why?
|
Health Care Surveys | 1 | 2014 | 2451 | 0.070 |
Why?
|
Risk Factors | 8 | 2023 | 72145 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2401 | 0.070 |
Why?
|
Thrombocytosis | 1 | 2006 | 81 | 0.070 |
Why?
|
HIV Antibodies | 1 | 2013 | 1320 | 0.070 |
Why?
|
Pain Measurement | 3 | 2022 | 3418 | 0.070 |
Why?
|
Immunoglobulin E | 2 | 2019 | 1460 | 0.070 |
Why?
|
Graft Rejection | 1 | 2019 | 4393 | 0.070 |
Why?
|
Cell Lineage | 1 | 2015 | 2504 | 0.070 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3847 | 0.070 |
Why?
|
Transcription, Genetic | 2 | 2017 | 7721 | 0.070 |
Why?
|
Carrier Proteins | 1 | 2019 | 5019 | 0.070 |
Why?
|
Interleukin-17 | 2 | 2023 | 900 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2283 | 0.070 |
Why?
|
Cyclooxygenase 2 | 1 | 2008 | 611 | 0.070 |
Why?
|
Antibodies, Antinuclear | 1 | 2006 | 326 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2017 | 6483 | 0.060 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1452 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1213 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16665 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1923 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 3001 | 0.060 |
Why?
|
Autoimmunity | 1 | 2012 | 1348 | 0.060 |
Why?
|
International Cooperation | 1 | 2011 | 1421 | 0.060 |
Why?
|
United States | 8 | 2022 | 69693 | 0.060 |
Why?
|
Middle Aged | 10 | 2021 | 213127 | 0.060 |
Why?
|
Cell Survival | 1 | 2014 | 5872 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3769 | 0.060 |
Why?
|
Activities of Daily Living | 1 | 2013 | 2414 | 0.060 |
Why?
|
Quality of Life | 5 | 2022 | 12730 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2014 | 2275 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2014 | 3038 | 0.060 |
Why?
|
Pain | 2 | 2021 | 4961 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4751 | 0.060 |
Why?
|
Interleukin-15 | 1 | 2023 | 184 | 0.050 |
Why?
|
Aging | 1 | 2022 | 8626 | 0.050 |
Why?
|
Genotype | 4 | 2020 | 12946 | 0.050 |
Why?
|
Gene Expression Profiling | 5 | 2019 | 9410 | 0.050 |
Why?
|
Eicosanoids | 1 | 2004 | 278 | 0.050 |
Why?
|
Mutation | 4 | 2023 | 29717 | 0.050 |
Why?
|
Retrospective Studies | 10 | 2023 | 77098 | 0.050 |
Why?
|
Capillaries | 1 | 2006 | 774 | 0.050 |
Why?
|
Apoptosis | 3 | 2015 | 9715 | 0.050 |
Why?
|
Immunization, Passive | 1 | 2004 | 625 | 0.050 |
Why?
|
Cytoplasmic Granules | 1 | 2004 | 610 | 0.050 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2006 | 364 | 0.050 |
Why?
|
HLA-DR Antigens | 1 | 2023 | 644 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2019 | 2187 | 0.050 |
Why?
|
Coculture Techniques | 2 | 2019 | 1341 | 0.050 |
Why?
|
Cathepsin G | 1 | 2021 | 32 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 7010 | 0.050 |
Why?
|
Heparin | 1 | 2009 | 1636 | 0.050 |
Why?
|
Mesoderm | 1 | 2004 | 686 | 0.050 |
Why?
|
Cell Nucleus | 2 | 2021 | 2968 | 0.050 |
Why?
|
Collagen | 1 | 2010 | 2684 | 0.050 |
Why?
|
Mitochondria | 1 | 2014 | 3520 | 0.050 |
Why?
|
Quassins | 1 | 2020 | 4 | 0.050 |
Why?
|
Myeloblastin | 1 | 2021 | 99 | 0.050 |
Why?
|
Common Variable Immunodeficiency | 1 | 2002 | 93 | 0.050 |
Why?
|
Fever of Unknown Origin | 1 | 2001 | 93 | 0.050 |
Why?
|
Coronary Vessels | 2 | 2019 | 3099 | 0.050 |
Why?
|
Organ Specificity | 1 | 2006 | 2003 | 0.050 |
Why?
|
Leukocyte Elastase | 1 | 2021 | 113 | 0.050 |
Why?
|
Oleanolic Acid | 1 | 2020 | 43 | 0.050 |
Why?
|
Particle Size | 2 | 2016 | 1640 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 2020 | 116 | 0.050 |
Why?
|
Enzyme Assays | 1 | 2021 | 111 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 264 | 0.050 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2020 | 30 | 0.050 |
Why?
|
Parents | 1 | 2014 | 3387 | 0.040 |
Why?
|
Musculoskeletal Diseases | 1 | 2006 | 581 | 0.040 |
Why?
|
Quantitative Trait Loci | 2 | 2018 | 2015 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9274 | 0.040 |
Why?
|
Fever | 2 | 2023 | 1612 | 0.040 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2019 | 107 | 0.040 |
Why?
|
Proteomics | 2 | 2023 | 3618 | 0.040 |
Why?
|
rab5 GTP-Binding Proteins | 1 | 2019 | 50 | 0.040 |
Why?
|
Serologic Tests | 1 | 2021 | 374 | 0.040 |
Why?
|
Cell Degranulation | 1 | 2020 | 287 | 0.040 |
Why?
|
Gene Frequency | 2 | 2018 | 3587 | 0.040 |
Why?
|
Pregnancy | 1 | 2021 | 29087 | 0.040 |
Why?
|
Calcium | 1 | 2012 | 5753 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2021 | 4200 | 0.040 |
Why?
|
Algorithms | 4 | 2021 | 13853 | 0.040 |
Why?
|
Ascites | 1 | 2020 | 344 | 0.040 |
Why?
|
Fathers | 1 | 2001 | 357 | 0.040 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2019 | 140 | 0.040 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2019 | 209 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Multiple Sclerosis | 1 | 2013 | 3076 | 0.040 |
Why?
|
Serum | 1 | 2019 | 212 | 0.040 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2019 | 2906 | 0.040 |
Why?
|
Injections, Intra-Articular | 1 | 2019 | 278 | 0.040 |
Why?
|
Janus Kinase 1 | 1 | 2017 | 104 | 0.040 |
Why?
|
Phagocytes | 1 | 2019 | 297 | 0.040 |
Why?
|
Macrophage-Activating Factors | 1 | 2017 | 21 | 0.040 |
Why?
|
Chromosome Mapping | 2 | 2018 | 4742 | 0.040 |
Why?
|
Macrophage Activation | 1 | 2020 | 558 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 2410 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 13029 | 0.040 |
Why?
|
Chemokine CXCL13 | 1 | 2017 | 54 | 0.040 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 711 | 0.040 |
Why?
|
High Mobility Group Proteins | 1 | 2017 | 187 | 0.040 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2019 | 494 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2019 | 471 | 0.040 |
Why?
|
Gene Expression | 2 | 2020 | 7790 | 0.040 |
Why?
|
Exanthema | 1 | 2001 | 488 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2021 | 1866 | 0.040 |
Why?
|
Uric Acid | 1 | 2022 | 760 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2017 | 5062 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5133 | 0.040 |
Why?
|
Immunoglobulin A | 1 | 2020 | 992 | 0.040 |
Why?
|
Peru | 1 | 2019 | 881 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2017 | 193 | 0.040 |
Why?
|
Immunoglobulin M | 1 | 2021 | 1538 | 0.030 |
Why?
|
Th1 Cells | 1 | 2021 | 1056 | 0.030 |
Why?
|
Young Adult | 6 | 2021 | 56350 | 0.030 |
Why?
|
Erythrocytes | 2 | 2016 | 2452 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2004 | 1389 | 0.030 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2017 | 307 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2017 | 3020 | 0.030 |
Why?
|
Genetic Variation | 2 | 2021 | 6540 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2017 | 315 | 0.030 |
Why?
|
Epigenomics | 1 | 2021 | 902 | 0.030 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2015 | 68 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 2524 | 0.030 |
Why?
|
Cohort Studies | 3 | 2018 | 40450 | 0.030 |
Why?
|
Stem Cells | 1 | 2008 | 3563 | 0.030 |
Why?
|
Cathepsin B | 1 | 2015 | 82 | 0.030 |
Why?
|
Bone Resorption | 1 | 2019 | 722 | 0.030 |
Why?
|
Rickettsia prowazekii | 1 | 2014 | 1 | 0.030 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15530 | 0.030 |
Why?
|
Cephalometry | 1 | 2016 | 382 | 0.030 |
Why?
|
Genitalia, Male | 1 | 2015 | 84 | 0.030 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 12071 | 0.030 |
Why?
|
Serotonin | 2 | 2012 | 1024 | 0.030 |
Why?
|
Microscopy | 1 | 2020 | 903 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 7901 | 0.030 |
Why?
|
Protein Binding | 2 | 2019 | 9387 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2018 | 947 | 0.030 |
Why?
|
Myocarditis | 1 | 2002 | 770 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2004 | 2633 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2015 | 642 | 0.030 |
Why?
|
Thrombin | 1 | 2016 | 598 | 0.030 |
Why?
|
Imidazoles | 1 | 2020 | 1205 | 0.030 |
Why?
|
Ketones | 1 | 2015 | 189 | 0.030 |
Why?
|
Cell Count | 1 | 2018 | 1831 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2015 | 297 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 35342 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2715 | 0.030 |
Why?
|
Hydrolysis | 1 | 2015 | 682 | 0.030 |
Why?
|
Receptors, Chemokine | 1 | 2017 | 669 | 0.030 |
Why?
|
Species Specificity | 1 | 2018 | 2479 | 0.030 |
Why?
|
Receptors, CCR | 1 | 2013 | 38 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2001 | 1786 | 0.030 |
Why?
|
Cadherins | 1 | 2018 | 906 | 0.030 |
Why?
|
Wrist Joint | 1 | 2015 | 256 | 0.030 |
Why?
|
Dipeptides | 1 | 2015 | 409 | 0.030 |
Why?
|
Anaphylaxis | 1 | 2020 | 746 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2018 | 1465 | 0.030 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2016 | 448 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2001 | 4187 | 0.030 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1573 | 0.030 |
Why?
|
Granzymes | 1 | 2013 | 270 | 0.030 |
Why?
|
Antigens, Dermatophagoides | 1 | 2012 | 100 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2019 | 1670 | 0.030 |
Why?
|
Complement Activation | 1 | 2013 | 452 | 0.030 |
Why?
|
Gadolinium | 1 | 2016 | 951 | 0.030 |
Why?
|
Peptide Library | 1 | 2013 | 350 | 0.030 |
Why?
|
Treatment Failure | 1 | 2017 | 2615 | 0.020 |
Why?
|
Escherichia coli | 1 | 2023 | 4214 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1314 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2021 | 6608 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2017 | 995 | 0.020 |
Why?
|
Ankle Joint | 1 | 2015 | 411 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2012 | 821 | 0.020 |
Why?
|
Aged | 4 | 2021 | 162944 | 0.020 |
Why?
|
Body Size | 1 | 2014 | 461 | 0.020 |
Why?
|
Antibody Specificity | 1 | 2013 | 1094 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 503 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7276 | 0.020 |
Why?
|
Canada | 1 | 2016 | 2061 | 0.020 |
Why?
|
Gap Junctions | 1 | 2012 | 233 | 0.020 |
Why?
|
Oligosaccharides | 1 | 2012 | 414 | 0.020 |
Why?
|
Antigens, CD | 1 | 2001 | 4024 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1727 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1503 | 0.020 |
Why?
|
Molecular Sequence Annotation | 1 | 2013 | 527 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2015 | 804 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2015 | 1875 | 0.020 |
Why?
|
Receptors, Collagen | 1 | 2010 | 26 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2022 | 3584 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2016 | 24913 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2019 | 6171 | 0.020 |
Why?
|
Incidence | 2 | 2023 | 20928 | 0.020 |
Why?
|
Interleukin-1alpha | 1 | 2010 | 84 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2842 | 0.020 |
Why?
|
Carcinogens | 1 | 2012 | 466 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2019 | 1860 | 0.020 |
Why?
|
Chromatin | 1 | 2021 | 2917 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2014 | 814 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 2680 | 0.020 |
Why?
|
Amino Acid Sequence | 2 | 2013 | 13814 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2012 | 1574 | 0.020 |
Why?
|
North America | 1 | 2012 | 1249 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5519 | 0.020 |
Why?
|
Leukotrienes | 1 | 2010 | 255 | 0.020 |
Why?
|
Bone and Bones | 1 | 2019 | 2575 | 0.020 |
Why?
|
Sulfotransferases | 1 | 2009 | 151 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1727 | 0.020 |
Why?
|
Homeostasis | 1 | 2019 | 3335 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2013 | 1995 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2016 | 1837 | 0.020 |
Why?
|
Amidohydrolases | 1 | 2009 | 169 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2013 | 18112 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12797 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 1066 | 0.020 |
Why?
|
DNA Methylation | 1 | 2021 | 4282 | 0.020 |
Why?
|
Crohn Disease | 1 | 2020 | 2301 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5180 | 0.020 |
Why?
|
DNA | 1 | 2001 | 7289 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2014 | 3139 | 0.020 |
Why?
|
Bacteria | 1 | 2018 | 2102 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2915 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3611 | 0.020 |
Why?
|
HIV Infections | 1 | 2013 | 16678 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4801 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2006 | 6454 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2203 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1038 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2022 | 9639 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3744 | 0.020 |
Why?
|
Virus Replication | 1 | 2013 | 2531 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3589 | 0.020 |
Why?
|
Glycoproteins | 1 | 2012 | 2260 | 0.020 |
Why?
|
Immune System | 1 | 2010 | 804 | 0.020 |
Why?
|
Histamine | 1 | 2006 | 507 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 2005 | 520 | 0.010 |
Why?
|
Quality Improvement | 1 | 2019 | 3738 | 0.010 |
Why?
|
Platelet Count | 1 | 2006 | 780 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5295 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57683 | 0.010 |
Why?
|
Ligands | 1 | 2010 | 3293 | 0.010 |
Why?
|
Likelihood Functions | 1 | 2006 | 1003 | 0.010 |
Why?
|
Data Collection | 1 | 2012 | 3339 | 0.010 |
Why?
|
Up-Regulation | 1 | 2012 | 4211 | 0.010 |
Why?
|
Self Report | 1 | 2014 | 3548 | 0.010 |
Why?
|
Rats | 1 | 2019 | 24265 | 0.010 |
Why?
|
Prospective Studies | 2 | 2017 | 53187 | 0.010 |
Why?
|
Proteins | 1 | 2017 | 6096 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2019 | 7873 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3455 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4455 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2010 | 2763 | 0.010 |
Why?
|
Giant Cells | 1 | 2002 | 187 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2018 | 9941 | 0.010 |
Why?
|
Boston | 1 | 2014 | 9305 | 0.010 |
Why?
|
Databases, Factual | 1 | 2015 | 7716 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1969 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19862 | 0.010 |
Why?
|
Physicians | 1 | 2016 | 4554 | 0.010 |
Why?
|
Comorbidity | 1 | 2011 | 10372 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2010 | 11363 | 0.010 |
Why?
|
Prognosis | 1 | 2015 | 29010 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2014 | 7645 | 0.010 |
Why?
|
Asthma | 1 | 2012 | 5955 | 0.010 |
Why?
|
Ultrasonography | 1 | 2006 | 5978 | 0.010 |
Why?
|
Echocardiography | 1 | 2005 | 5097 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39004 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2002 | 3119 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2006 | 25575 | 0.000 |
Why?
|